Keywords: schering-plough, eps, increases, fourth-quarter, net, income, rose
Schering-Plough EPS increases 14.7%
Article | 26 January 2001
Schering-Plough's fourth-quarter 2000 net income rose 12.8% to $571million, or $0.39 per share (+14.7%), as sales increased 6% to $2.42 billion. Worldwide pharmaceutical sales in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
